-
Enough is enough! Don’t infect the vaccine with politics
It is the all-round politicisation of the vaccine challenge that has forced the citizen to lose hope and confidence in the political establishment
-
On-spot registration for 18-44 age group at private centres will boost vaccination drive
Lack of technological awareness should not be the reason for someone missing out on the vaccine
-
Serum Institute seeks test licence from DCGI to manufacture Covid vaccine Sputnik V
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories
-
SC directs govt to place on record documents, file notings on Covid vaccination policy
The top court also asked the Centre to specify the steps being taken by it to ensure drug availability for mucormycosis or black fungus
-
Aarogya Setu will feature blue tick upon vaccination
Welcoming the move, industry veterans wondered whether it could be used by the government as a 'gate pass' in airports, railway stations and other pub
-
Over 1.64 crore Covid-19 vaccines still available with states: Centre
The Centre has so far provided, both through the free of cost and through direct state procurement categories, more than 23 crore vaccine doses to s
-
Covid-19: States, UTs have stock of more than 1.57 crore vaccines
The Centre has so far provided, both through the free of cost and through direct state procurement categories, more than 23 crore vaccine doses to sta
-
Greenpeace India writes to WTO to end patent rights on Covid-19 vaccines
WTO's decision on intellectual property and patent rights on vaccines could either strengthen the fight against the Covid pandemic or lead to a battle
-
Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech
The timeline for manufacturing, testing and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regula
-
Compulsory licensing for vaccines not very attractive option: NITI Aayog’s VK Paul
VK Paul noted that technology transfer is the key and that remains in the hands of the company that has carried out R&D
